Teladoc Health Inc.
TDOC | NYSE
$6.22
-$0.05 (-0.80%)
Sep 22, 2026, 11:56 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.53B | 2.57B | 2.6B | 2.41B | 2.03B | 1.09B |
Cost of Revenue | 771.59M | 751.27M | 760.03M | 743.99M | 650.26M | 390.83M |
Gross Profit | 1.76B | 1.82B | 1.84B | 1.66B | 1.38B | 703.13M |
Operating Income | -262.96M | -1.02B | -248.55M | -13.65B | -265.63M | -506.42M |
Interest Income | 36.77M | 57.07M | 46.78M | 12.67M | 776K | n/a |
Pretax Income | -235.53M | -993.65M | -219.61M | -13.66B | -384.66M | -575.99M |
Net Income | -200.32M | -1B | -220.37M | -13.66B | -428.79M | -485.14M |
Selling & General & Admin | 1.09B | 1.35B | 1.37B | 1.3B | 1.11B | 886.88M |
Research & Development | 277.92M | 307.27M | 348.52M | 333.63M | 311.88M | 164.94M |
Other Expenses | 658.15M | 1.19B | 375.12M | 13.68B | 230.88M | 157.73M |
Operating Expenses | 2.02B | 2.84B | 2.09B | 15.32B | 1.65B | 1.21B |
Interest Expense | 19.71M | 23.8M | 22.28M | 21.94M | 81.14M | 59.95M |
Selling & Marketing Expenses | 653.37M | 910.78M | 902.63M | 850.71M | 667.31M | 380.2M |
Cost & Expenses | 2.79B | 3.59B | 2.85B | 16.06B | 2.3B | 1.6B |
Income Tax Expense | -35.21M | 7.59M | 760K | -3.81M | 44.14M | -90.86M |
Shares Outstanding (Basic) | 176.22M | 170.56M | 162.17M | 161.46M | 156.94M | 90.51M |
Shares Outstanding (Diluted) | 176.22M | 170.56M | 164.58M | 161.46M | 156.94M | 90.51M |
EPS (Basic) | -1.14 | -5.87 | -1.36 | -84.60 | -2.73 | -5.36 |
EPS (Diluted) | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 | -5.36 |
EBITDA | 147.3M | 31.72M | 43.61M | -7.54M | -31.42M | -354.49M |
EBIT | -215.82M | -208.79M | -210.5M | -217.47M | -238.99M | -418.19M |
Depreciation & Amortization | 363.12M | 240.51M | 254.11M | 209.93M | 207.57M | 63.69M |
Add to Watchlist
Select watchlists to add or remove TDOC